Muhammad G Kibriya is a Research Associate Professor at the Institute for Population and Precision Health (IPPH), Department of Public Health Sciences (PHS), Biological Sciences Division at the University of Chicago. He received an MB BS from the Institute for Postgraduate Medicine & Research, Dhaka University, in 1987 and a PhD in Medicine from the Medical Academy Sofia, Bulgaria, in 1994. He has been trained in medicine, nephrology, diabetology, epidemiology, environmental health, and cancer genomics. His research interests include integrative molecular genomics, gene–environmental interaction in cancer epidemiology, oncogenesis and its application in disease classification, and the therapeutic response and prognosis of different human cancers including colorectal, breast, thyroid, and non-melanoma skin cancer. He is a co-investigator in multiple large-scale cohorts like Health Effects of Arsenic Longitudinal Studies (HEALS), the Bangladesh vitamin E and Selenium Trial (BEST), the ChicagO Multiethnic Prevention And Surveillance Study (COMPASS), and NCI-CONNECT. He developed a novel non-PCR-based, high-throughput, cost-effective assay on the Luminex platform for the measurement of relative telomere length that has been used in multiple large-scale epidemiologic studies.